- Home
- TVTX vs TIC Comparison
TVTX vs TIC Comparison
Compare TVTX & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- TIC
- Stock Information
- Founded
- TVTX 2008
- TIC 1991
- Country
- TVTX United States
- TIC United States
- Employees
- TVTX N/A
- TIC N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- TIC
- Sector
- TVTX Health Care
- TIC
- Exchange
- TVTX Nasdaq
- TIC Nasdaq
- Market Cap
- TVTX 1.3B
- TIC 1.5B
- IPO Year
- TVTX N/A
- TIC N/A
- Fundamental
- Price
- TVTX $14.92
- TIC $9.70
- Analyst Decision
- TVTX Strong Buy
- TIC Hold
- Analyst Count
- TVTX 13
- TIC 1
- Target Price
- TVTX $33.75
- TIC $13.00
- AVG Volume (30 Days)
- TVTX 2.0M
- TIC 256.8K
- Earning Date
- TVTX 05-05-2025
- TIC 05-27-2025
- Dividend Yield
- TVTX N/A
- TIC N/A
- EPS Growth
- TVTX N/A
- TIC N/A
- EPS
- TVTX N/A
- TIC N/A
- Revenue
- TVTX $233,175,000.00
- TIC $1,097,393,000.00
- Revenue This Year
- TVTX $68.31
- TIC N/A
- Revenue Next Year
- TVTX $55.65
- TIC N/A
- P/E Ratio
- TVTX N/A
- TIC N/A
- Revenue Growth
- TVTX 60.55
- TIC 4.51
- 52 Week Low
- TVTX $5.12
- TIC $2.39
- 52 Week High
- TVTX $25.29
- TIC $2.60
- Technical
- Relative Strength Index (RSI)
- TVTX 37.07
- TIC N/A
- Support Level
- TVTX $14.13
- TIC N/A
- Resistance Level
- TVTX $15.23
- TIC N/A
- Average True Range (ATR)
- TVTX 1.31
- TIC 0.00
- MACD
- TVTX -0.10
- TIC 0.00
- Stochastic Oscillator
- TVTX 31.70
- TIC 0.00
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.